Typicality: | 0.274 |
Saliency: | 0.058 |
to erlotinib | 4 | location |
to inis | 2 | location |
mutation → be associated with → primary resistance | 4 |
negative | neutral | positive |
0.246 | 0.698 | 0.056 |
Raw frequency | 4 |
Normalized frequency | 0.058 |
Modifier score | 0.500 |
Perplexity | 388.130 |